Barclays’s AMN Healthcare AMN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-4,100
Closed -$340K – 4532
2023
Q1
$340K Buy
+4,100
New +$386K ﹤0.01% 3515
2019
Q1
– Sell
-100,000
Closed -$5.67M – 6982
2018
Q4
$5.67M Sell
100,000
-326,100
-77% -$18.3M ﹤0.01% 1515
2018
Q3
$23.3M Buy
+426,100
New +$24.4M 0.02% 767

Other funds holding AMN

Barclays's AMN Position: Q3 2026 in Review

Barclays increased its AMN Healthcare (AMN) stake by 2,457% in Q3 2026, buying an estimated $5.46M and bringing the position to 167,060 shares worth $5.99M. The position accounts for ﹤0.01% of the portfolio, ranked #1932.

Barclays first reported a position in AMN in Q2 2013 and has held it in 54 quarters since. The position peaked at $13.3M in Q2 2025. 123 funds tracked by Wall St. Rank hold AMN as of Q3 2026.

  • Barclays held 167,060 shares of AMN Healthcare worth $5.99M as of Q3 2026.
  • Barclays bought 160,527 AMN Healthcare shares in Q3 2026, an estimated $5.46M.
  • AMN Healthcare made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #1932 holding.
  • Barclays first reported a position in AMN Healthcare in Q2 2013 and has held it in 54 quarters since.
  • Barclays's AMN Healthcare position peaked at $13.3M in Q2 2025.
  • 123 funds tracked by Wall St. Rank held AMN Healthcare as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.